Circulating Adipocytokines and Chronic Kidney Disease

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Mills, Katherine T ^a   Hamm, L Lee ^b   Alper, A Brent ^b   Miller, Chad ^b   Hudaihed, Alhakam ^b   Balamuthusamy, Saravanan ^b   Chen, Chung Shiuan ^a   Liu, Yanxi ^a   Tarsia, Joseph ^b   Rifai, Nader ^c,d   Kleinpeter, Myra ^b   He, Jiang ^a,b   Chen, Jing ^a,b  

^a TULANE UNIVERSITY   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RESISTIN;

ADULT; AGED; ALBUMINURIA; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATHOGENESIS; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; URINE LEVEL; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; AGED; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; LEPTIN; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RENAL INSUFFICIENCY, CHRONIC; RESISTIN; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84885041594     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076902     Document Type: Article

References (31)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, et al. (2007) Prevalence of chronic kidney disease in the united states. JAMA 298: 2038-2047.
2. Levey AS, Coresh J, (2012) Chronic kidney disease. Lancet 379: 165-180.
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY, (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305.
4. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, et al. (2001) Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286: 421-426.
5. Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, Woodward M, et al. (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet 375: 2073-2081.
6. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, et al. (2004) Predictors of new-onset kidney disease in a community-based population. JAMA 291: 844-850.
7. Schiffrin EL, Lipman ML, Mann JF, (2007) Chronic kidney disease: Effects on the cardiovascular system. Circulation 116: 85-97.
8. Ntaios G, Gatselis NK, Makaritsis K, Dalekos GN, (2013) Adipokines as mediators of endothelial function and atherosclerosis. Atherosclerosis 227: 216-221.
9. Merabet E, Dagogo-Jack S, Coyne DW, Klein S, Santiago JV, et al. (1997) Increased plasma leptin concentration in end-stage renal disease. J Clin Endocrinol Metab 82: 847-850.
10. Sharma K, Considine RV, Michael B, Dunn SR, Weisberg LS, et al. (1997) Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 51: 1980-1985.
11. Nordfors L, Lonnqvist F, Heimburger O, Danielsson A, Schalling M, et al. (1998) Low leptin gene expression and hyperleptinemia in chronic renal failure. Kidney Int 54: 1267-1275.
12. Fruehwald-Schultes B, Kern W, Beyer J, Forst T, Pfutzner A, et al. (1999) Elevated serum leptin concentrations in type 2 diabetic patients with microalbuminuria and macroalbuminuria. Metabolism 48: 1290-1293.
13. Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A, Fouque D, (2005) Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant 20: 129-134.
14. Shankar A, Syamala S, Xiao J, Muntner P, (2012) Relationship between plasma leptin level and chronic kidney disease. Int J Nephrol 2012: 269532.
15. de Vinuesa SG, Goicoechea M, Kanter J, Puerta M, Cachofeiro V, et al. (2006) Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic kidney disease: Effects of angiotensin II blockade. J Am Soc Nephrol 17: S206-12.
16. Axelsson J, Bergsten A, Qureshi AR, Heimburger O, Barany P, et al. (2006) Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int 69: 596-604.
17. Yaturu S, Reddy RD, Rains J, Jain SK, (2007) Plasma and urine levels of resistin and adiponectin in chronic kidney disease. Cytokine 37: 1-5.
18. Kawamura R, Doi Y, Osawa H, Ninomiya T, Hata J, et al. (2010) Circulating resistin is increased with decreasing renal function in a general japanese population: The hisayama study. Nephrol Dial Transplant 25: 3236-3240.
19. Norata GD, Baragetti I, Raselli S, Stucchi A, Garlaschelli K, et al. (2010) Plasma adiponectin levels in chronic kidney disease patients: Relation with molecular inflammatory profile and metabolic status. Nutr Metab Cardiovasc Dis 20: 56-63.
20. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, et al. (2002) Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13: 134-141.
21. Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, et al. (2005) Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: The mild and moderate kidney disease study. J Am Soc Nephrol 16: 1091-1098.
22. Perloff D, Grim C, Flack J, Frohlich ED, Hill M, et al. (1993) Human blood pressure determination by sphygmomanometry. Circulation 88: 2460-2470.
23. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, et al. (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612.
24. Hsieh CC, Maisonneuve P, Boyle P, Macfarlane GJ, Roberston C, (1991) Analysis of quantitative data by quantiles in epidemiologic studies: Classification according to cases, noncases, or all subjects? Epidemiology 2: 137-140.
25. Sarnak MJ, Poindexter A, Wang SR, Beck GJ, Kusek JW, et al. (2002) Serum C-reactive protein and leptin as predictors of kidney disease progression in the modification of diet in renal disease study. Kidney Int 62: 2208-2215.
26. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, et al. (1999) Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 100: 2473-2476.
27. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, et al. (2000) Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102: 1296-1301.
28. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, et al. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595-1599.
29. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, et al. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930-1935.
30. Nanayakkara PW, Le Poole CY, Fouque D, van Guldener C, Stehouwer CD, et al. (2009) Plasma adiponectin concentration has an inverse and a non linear association with estimated glomerular filtration rate in patients with K/DOQI 3- 5 chronic kidney disease. Clin Nephrol 72: 21-30.
31. Kollerits B, Fliser D, Heid IM, Ritz E, Kronenberg F, et al. (2007) Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: The mild to moderate kidney disease study. Kidney Int 71: 1279-1286.